Figure 3From: Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer Comparison of DFS rates among different chemotherapy subgroups in patients with low TopIIα expression. (A) depicts comparison of DFS curves between the NVB regimen group and the group of other regimens without NVB; (B) depicts comparison of DFS curves among four chemotherapy subgroupsBack to article page